Lilly $1.4B Zyprexa Settlement Is Biggest Ever, But Some State Claims Still Pending
This article was originally published in The Pink Sheet Daily
Criminal and civil penalties stem from a “commitment to off-label marketing” with 2,000 sales reps, U.S. Attorney Magid says.
You may also be interested in...
Budget proposal to fund state Medicaid programs through per capita cap or block grant would save $610bn over 10 years, administration says; budget calls for clarifying treatment of value-based pricing and fostering exchange of pre-approval information between manufacturers and payers.
Abbott Laboratories is the third pharmaceutical company to reach a settlement with the Department of Justice in excess of $1 billion. A look at the deals struck since Eli Lilly began the billion dollar club in 2009 shows the activities the government is investigating and the level of liability that companies face.
CMS’ proposal to reduce overprescribing in nursing homes draws cautiously favorable response from national pharmacist group, but long-term care pharmacy firm Omnicare argues the agency has not provided adequate justification for its plan.